PMCB PHARMACYTE BIOT

NASDAQ
$0.54

PHARMACYTE BIOT (PMCB) Seasonality

What this stock has historically done over the three months following this point in the calendar year, measured against every other three-month stretch on record.

The three months from August 26

From August, on average
-11.65%
55 matching years
Any three months
+572.20%
2,841 starting points
Difference
-583.9 pts
worse than usual

Both lines start at zero on day 0, so the vertical gap reads directly as percentage points better or worse than a random three months. A seasonal line sitting on top of the baseline is a real answer: it says the calendar tells you nothing here. Price history from January 2015 to August 2026.

Between earnings releases

The same study run on the earnings cycle rather than the calendar: the average move from one report to the next, broken out by fiscal quarter, with the announcement gap and the run-up separated out.

Sign in or subscribe to see it